Protocol details: Dose: 5-10 ml per day Route: Intramuscular or slow IV injection Frequency: 5 days per week Duration: 4 weeks per cycle Rest period: 8 weeks between cycles Cycles: 2-4 per year based on response Expected timeline: Week 1-2: Subtle changes in mental clarity reported by some individuals Week 3-4: Measurable cognitive improvements on standardized tests Week 4-12: Sustained improvements maintained through rest period Month 6+: Cumulative benefits with repeated cycles This protocol mirrors the Alzheimer disease trials that showed maintained improvement at week 28, three months after a 4-week treatment course
A number of factors can increase the risk of developing seborrheic dermatitis, including neurologic and psychiatric conditions, a weakened immune system, recovery from stressful medical conditions as well as several medications
For instance, imbalances within the neuroendocrine system, particularly involving the hypothalamic-pituitary-adrenal (HPA) axis, can severely disrupt hormonal balance, resulting in cognitive and behavioral impairments (Schipper, 2016)
Molena D, Schlottmann F, Boys JA, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL , Lada MJ, Louie BE, Mungo B, Watson TJ, DeMeester SR
* Use: For laboratory research use only
(2012) Induction of biogenic magnetization and redox control by a component of the target of rapamycin complex 1 signaling pathway PLoS Biol., 10: e1001269 29